Quick Takeaways
- WELLINGTON MANAGEMENT GROUP LLP filed SCHEDULE 13G/A for Syndax Pharmaceuticals, Inc. Common Stock (SNDX).
- Disclosed ownership: 0%.
- Date of event: 28 Feb 2025.
WELLINGTON MANAGEMENT GROUP LLP - 28 Feb 2025 SCHEDULE 13G/A Report for Syndax Pharmaceuticals, Inc. Common Stock (SNDX)
- Filing Manager
- WELLINGTON MANAGEMENT GROUP LLP
- Reporting Manager
- Wellington Management Group LLP
- Symbol
- SNDX
- Disclosed Ownership
- 35,681 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Mar 2025, 11:13:24 UTC
- Date of event
- 28 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WELLINGTON MANAGEMENT GROUP LLP disclosed 0% ownership in Syndax Pharmaceuticals, Inc. Common Stock (SNDX) on 28 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Mar 2025, 11:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 0% | 35,681 | 0 | 32,075 | Taisia Lowe | Regulatory Analyst | |
| Wellington Group Holdings LLP | 0% | 35,681 | 0 | 32,075 | Taisia Lowe | Regulatory Analyst | |
| Wellington Investment Advisors Holdings LLP | 0% | 35,681 | 0 | 32,075 | Taisia Lowe | Regulatory Analyst |